Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
- Findings Published in Blood -
SAN DIEGO, Aug. 30 /PRNewswire/ -- Novocell Inc., a stem cell
engineering company, today announced research findings that for the first
time identify two prominent cancer cell signaling pathways as essential for
the efficient
proliferation an...
Cell Proliferation Assays
Abstract
The cell
proliferation assay is an important tool in the assessment of the immune system function and in the search for new drugs. Productivity with this technique has been limited by the lack of automated, high throughput sample processing and counting equipment. Th...
Identification of cells in S phase using the Cell Proliferation Fluorescence Kit and IN Cell Analyzer 1000
The cell cycle is of key importance to many areas of drug discovery. On the one hand this fundamental process provides the opportunity to discover new therapeutic targets for anti-cancer agents, and on the other hand drugs and targets in other therapeutic areas must be tested ...
Cell Proliferation Assay Using the Benchmark Plus Microplate Spectrophotometer
William C Heiser, PhD and Ma Theresa Redila-Flores, Bio-Rad Laboratories,
Inc . , Hercules, CA 94547 USA
Introduction
An accurate and rapid assessment of viable cell number and
proliferation
is often required for in vitro and i...
measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay
SPECTRAMAX APPLICATION NOTE
Cathy Olsen, Ph.D., Molecular Devices Corporation, 1311 Orleans Dr.,
Sunnyvale, CA 94089.
INTRODUCTION
The Molecular Devices SpectraMax M5 and
M2...
Cell Proliferation and Viability Measurement
The quantification of cellular growth, including proliferation
and viability, has become an essential tool in any
laboratory working on cell-based studies. Such techniques
enable not only the optimization of cell culture
...
Cell Proliferation Kit Outperforms the Competition in the Range of Cells
Typically Counted
Quantitating cell number is more accurate using the Quantos cell
proliferation assay kit
Leslie S. Arrington
Genetic Applications LLC
The Quantos cell
proliferation assay kit
provides a simple, reproducible method to assess the number of cells present in
v...
Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody
... cancer stem cell frequency, thereby delaying the re-growth or recurrence of tumors, anti-DLL4 therapy was shown to reduce tumor growth and tumor cell
proliferation and disrupt tumor angiogenesis. Moreover, OMP-21M18 displayed additive activity in reducing tumor volume when combined with traditional chemotherapy....
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
...ssue repair and lower the overall level of protein required.
Growth Factor Gene Portfolio
Growth factor proteins stimulate cellular
proliferation and cellular differentiation. Growth factors regulate a variety of cellular processes, as well as other signaling molecules, which play key roles in ...
Sunesis Reports Financial Results for the Second Quarter 2009
...stant ovarian cancer.
About Acute Myeloid Leukemia
AML is a rapidly progressing cancer of the blood characterized by the uncontrolled
proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approxima...
Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
...by a patient's own cells directly at the wound site is believed to stimulate angiogenesis and granulation tissue formation through the recruitment and
proliferation of cells such as monocytes, fibroblasts and endothelial cells. These cell types are critical for the effective stimulation of a variety of wound heal...
Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
...factors slowing down growth in the global prescription drugs market include economic downturn, increasing number of drugs going off patent, increasing
proliferation of generics, falling drug costs, and fewer new drug approvals. On the positive side, the market is experiencing increased demand for biologics, biopha...
Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
... glioma, colon, ovarian, prostate and melanoma, where it leads to increased
proliferation and inhibition of apoptosis (programmed cell death). PX-866 has been shown ...also provides control over a number of transcription factors affecting cell
proliferation and death through the mechanism of redox regulation.
An initial Phase 1 t...
Gene Network Sciences Announces Broad Cancer Collaboration With UCSF and Initial Results
...ve utilized REFS(TM) to discover and validate novel mediators of the cell cycle transition, which is a critical determinant of the rate of cancer cell
proliferation and tumor growth. These results were presented by UCSF researcher Dr. Rina Gendelman, a post-doctoral fellow in Dr. W. Michael Korn's laboratory, at t...
Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis
...nase is implicated in a large proportion of human cancers including breast, glioma, colon, ovarian, prostate and melanoma, where it leads to increased
proliferation and inhibition of apoptosis (programmed cell death). PX-866 has been shown to induce prolonged inhibition of tumor PI-3 kinase signaling following bot...
Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Children's Hospital Boston and Massachusetts General Hospital
...erved mechanisms from developmental biology and tissue repair has led to the identification of small molecules and biologics that can direct stem cell
proliferation and function. Fate Therapeutics is developing these small molecule and biologic SCMs to modulate the activity of adult stem cells to stimulate healin...
Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting
...l and tumor vasculature. In preclinical studies, Nexavar has been shown to target members of two classes of kinases known to be involved in both cell
proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VE...
Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor
...gin a phase I clinical study with its selective PLK-1 small molecule
inhibitor for the treatment of cancer. PLK-1 is a mitotic kinase required for
the
proliferation of cancer cells. This new compound is orally bioavailable,
highly efficient and well tolerated in preclinical models of cancer after
repeated dosing. ...
Preclinical Data From Amgen's Oncology Pipeline to be Presented at AACR
... AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell
proliferation through disruption of the P13K/Akt and MAPK pathways
Overview: Eval...ated the effect of a novel antibody to the IGF-1R (AMG
479) on cell
proliferation and expression of key targets involved in
IGF-1R signaling in endom...
Cell Biosciences Launches Next-Generation Protein Characterization System
... in the fields of cancer research, stem cell biology, and diabetes. Our products enable researchers to uncover fundamental mechanisms controlling cell
proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers. Cell Bioscie...
Cell Biosciences Announces Publication in Nature Medicine
... in the fields of cancer research, stem cell biology, and diabetes. Our products enable researchers to uncover fundamental mechanisms controlling cell
proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers. Cell Bioscie...
Cell Biosciences Closes $10 Million Series C Financing
...in the fields of cancer research, stem cell biology, and diabetes. Our products enable researchers to uncover fundamental mechanisms controlling cell
proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers. Cell Biosci...
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
...um-resistant ovarian cancer.
About Acute Myeloid Leukemia
AML is a rapidly progressing cancer of the blood characterized by the uncontrolled
proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approxima...
Agencies Unite to Launch Donor Network Alliance: First-Ever Web-Based Collective of Egg Donor Candidates
... of Chicago.
"DNA is needed as the fertility field grows in size and complexity," said Robin von Halle, president of ARR. "This has resulted in a
proliferation of agencies that recruit egg donors, which makes weighing agency and donor choices more costly, confusing and time consuming for intended parents."
...
Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million
...sionals can visit www.zevalin.com for more information.
About Non-Hodgkin's Lymphoma
Non-Hodgkin's lymphoma (NHL) is caused by the abnormal
proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classi...
FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
...l to conduct for the first time clinical trials of a novel
antitumoral agent. The drug blocks Cdc7, a protein that is responsible for
the uncontrolled
proliferation of cancer cells. The preclinical data,
recently published on the prestigious journal Nature Chemical Biology (
http://www.nature.com/nchembio/journal...
EAU Technologies Receives Patent for Empowered Water(TM)
...d to clean, disinfect and nourish in large industries such as agriculture and food processing. EAU has solutions for existing bacteria, virus and mold
proliferation threats. EAU continues to add innovative and efficacious products that offer a systemic approach to pathogen elimination in food processing plants and...
Sunesis Pharmaceuticals Provides Year-End Clinical Update on Voreloxin
...-resistant ovarian cancer.
About Acute Myeloid Leukemia
AML is a rapidly progressing cancer of the blood characterized by the uncontrolled
proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approxim...
Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells
...tivity."
About AML
AML (acute myeloblastic leukemia ) is a cancer of the myeloid line of white blood cells, characterized by the rapid
proliferation of abnormal cells which accumulate in the bone marrow and interfere with the production of normal blood cells. AML is a potentially curable disease; ...
Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting
...e
viewed on the ASH website at http://www.hematology.org .
Syk Inhibitor Program
"Specific Inhibition of Syk is Sufficient to Disrupt
proliferation and
Survival of Non-Hodgkin's Lymphoma Cell Lines without Concomitant Inhibition
of JAK" (abstract # 1794)
Saturday, December 6, 5:30 PM
H...
FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review
...sit http://www.zevalin.com for
more information.
About Non-Hodgkin's Lymphoma
Non-Hodgkin's lymphoma (NHL) is caused by the abnormal
proliferation of
white blood cells and normally spreads through the lymphatic system, a system
of vessels that drains fluid from the body. NHL can be broadly classi...
Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
...licular NHL.
Non-Hodgkin's lymphoma (NHL) is caused by the abnormal
proliferation of
white blood cells and normally spreads through the lymphatic system, a s...n's Lymphoma
Non-Hodgkin's lymphoma (NHL) is caused by the abnormal
proliferation of
white blood cells and normally spreads through the lymphatic system, a s...
Solar power game-changer: 'Near perfect' absorption of sunlight, from all angles
...away and thus unharvestable. From an economic and efficiency perspective, this unharvested light is wasted potential and a major barrier hampering the
proliferation and widespread adoption of solar power.
After a silicon surface was treated with Lin's new nanoengineered reflective coating, however, the material...
Abbott's XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
...t and supplied to Boston
Scientific as part of a distribution agreement between the two companies.
Everolimus, developed by Novartis Pharma AG, is a
proliferation signal
inhibitor, or mTOR inhibitor, licensed to Abbott by Novartis for use on its
drug eluting stents. Everolimus has been shown to inhibit in-stent
...
High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin's Lymphoma
...onals can visit http://www.zevalin.com
for more information.
About Non-Hodgkin's Lymphoma
Non-Hodgkin's lymphoma (NHL) is caused by the abnormal
proliferation of
white blood cells and normally spreads through the lymphatic system, a
system of vessels that drains fluid from the body. NHL can be broadly
classi...
CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C.
...shington, D.C. next week.
The presentation entitled "Cell Therapy Devices and Concepts: Acellular
Matrix Emulsion Injections to Induce Myofibroblast
proliferation and
Angiogenesis" will take place on Monday, October 13th at 1:35 p.m. EDT in
room 145AB as part of the Innovative Devices and Futuristic Therapies
Se...
Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
...Macrophage Inflammatory Protein 1 alpha), MCP-1
(Monocyte Chemoattractant Protein-1), IP-10 (Inducible Protein 10) and
PGE-2 (Prostaglandin E-2). Cell
proliferation assay (XTT reduction)
demonstrated that these effects were not caused by cytotoxicity. The
anti-inflammatory efficacy was comparable or better than th...
Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
...onals can visit http://www.zevalin.com
for more information.
About Non-Hodgkin's Lymphoma
Non-Hodgkin's lymphoma (NHL) is caused by the abnormal
proliferation of
white blood cells and normally spreads through the lymphatic system, a
system of vessels that drains fluid from the body. NHL can be broadly
classi...
FDA Meeting Provides Green Light for Cell Therapeutics Submission of Supplemental Filing for Zevalin(R) Label Expansion
...onals can visit http://www.zevalin.com
for more information.
About Non-Hodgkin's Lymphoma
Non-Hodgkin's lymphoma (NHL) is caused by the abnormal
proliferation of
white blood cells and normally spreads through the lymphatic system, a
system of vessels that drains fluid from the body. NHL can be broadly
classi...
Old and new therapies combine to tackle atherosclerosis
...Patients with atherosclerosis often take statins to lower cholesterol. Statins also decrease atherosclerotic plaque progression by modestly inhibiting
proliferation of new vessels (neovessels) within plaques. These neovessels provide increased blood and oxygen to cells in actively developing plaques. Because of th...